Cover Image
市場調查報告書

歐洲的體外診斷 (IVD) 市場 (2016∼2020年)

IVD Market in Europe 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 357367
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
歐洲的體外診斷 (IVD) 市場 (2016∼2020年) IVD Market in Europe 2016-2020
出版日期: 2016年04月28日 內容資訊: 英文 71 Pages
簡介

所謂體外診斷 (IVD) 檢驗,是在受控制的環境下診斷、觀察、評估症狀、疾病、感染疾病等。透過控制檢驗次序和正確的檢驗結果,可實現疾病的早期診斷,提高品管和縮短住院期的效果。還有侵入性很低,實施費用也很低的優點。在廠商方面進行著試劑和診斷設備 (自動分析設備等),配件 (軟體等) 開發。歐洲的IVD市場,預計2016∼2020年以4.78%的年複合成長率成長。

本報告提供歐洲各國的體外診斷 (以下IVD) 市場相關分析,技術概要和市場基本結構,市場規模趨勢 (今後5年的預測值),各用途、各地區的詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品與服務

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第6章 各應用領域的市場區隔

  • POCT (就地檢驗) 設備市場
  • 免疫診斷市場
  • 血糖監測系統市場
  • 分子診斷市場
  • 血液檢查裝置市場
  • 微生物檢驗設備市場
  • 組織診斷市場
  • 血液凝固檢查設備市場

第7章 地區區分

  • 德國的IVD市場
  • 法國的IVD市場
  • 英國的IVD市場
  • 義大利的IVD市場
  • 西班牙的IVD市場
  • 荷比盧三國的IVD市場
  • 北歐各國的IVD市場

第8章 推動市場要素

  • 慢性疾病、感染疾病的高得病率
  • 早期診斷、預防的興趣
  • 一般的認識度的提高

第9章 推動因素的影響力

第10章 市場課題

  • 供應商和中小企業的競爭
  • 醫療費償付額和價格結構
  • 能使用POC (照護現場) 用IVD設備的技術純熟勞工的不足
  • POCT技術的限制

第11章 推動因素、課題的影響力

第12章 市場趨勢

  • 對即時/數位化治療的著重
  • 使用DNA探針的診斷技術的有效利用
  • 企業合併、收購 (M&A) 的增加

第13章 供應商環境

  • 競爭方案
  • Abbott Diagnostics
  • Beckman Coulter
  • Becton, Dickinson
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • 其他卓越供應商

第14章 附錄

  • 簡稱集

第15章 關於Technavio

圖表一覽

目錄
Product Code: IRTNTR8413

About IVD Market in Europe

IVD tests help diagnose, monitor, and assess medical conditions, diseases, and infections in a controlled environment. These tests help in early diagnosis of diseases by enhancing control on test procedures and provide accurate results, leading to quality treatment and shorter hospital stays. They are also minimally invasive and help in lowering treatment costs. Manufacturers develop reagents, analytical instruments such as automated analyzers, and accessory products including software to measure the quality and parameters of samples.

Technavio's analysts forecast the IVD market in Europe to grow at a CAGR of 4.78% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the IVD market in Europe for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of IVD consumables and instruments in EU27 countries.

The market is divided into the following segments based on geography:

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Benelux
  • Nordic

Technavio's report, IVD Market in Europe 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Beckman Coulter, Inc
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc

Other Prominent Vendors

  • Abaxis
  • A. Menarini Diagnostics
  • Acon Laboratories
  • Bio-Rad Laboratories
  • Cepheid
  • Chembio Diagnostic Systems
  • Clarity Diagnostics
  • DiagCor
  • Helena Laboratories
  • Hologic
  • i-Sens
  • Landwind Medical
  • Mindray
  • Nipro Diagnostics
  • Randox Laboratories
  • Snibe Diagnostics
  • Span Diagnostics
  • Sysmex
  • Trivitron Healthcare
  • URIT

Market driver

  • High prevalence of chronic diseases and infections
  • For a full, detailed list, view our report

Market challenge

  • Competition among vendors and SMEs
  • For a full, detailed list, view our report

Market trend

  • Use of DNA probe-based diagnostics
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by application

  • POCT devices market in Europe
  • Immunodiagnostics market in Europe
  • Blood glucose monitoring devices market in Europe
  • Molecular diagnostics market in Europe
  • Hematology devices market in Europe
  • Microbiology devices market in Europe
  • Tissue diagnostics market in Europe
  • Coagulation testing devices market in Europe

PART 07: Geographical segmentation

  • IVD market in Germany
  • IVD market in France
  • IVD market in UK
  • IVD market in Italy
  • IVD market in Spain
  • IVD market in Benelux
  • IVD market in Nordic countries

PART 08: Market drivers

  • High prevalence of chronic diseases and infections
  • Focus on early diagnosis and prevention
  • Rise in public awareness

PART 09: Impact of drivers

PART 10: Market challenges

  • Competition among vendors and SMEs
  • Reimbursement and pricing structure
  • Lack of skill in using POC IVD devices
  • Limitations of POCT technology

PART 11: Impact of drivers and challenges

PART 12: Market trends

  • Focus on real-time and digitalized treatment
  • Use of DNA probe-based diagnostics
  • Increase in M&A

PART 13: Vendor landscape

  • Competitive scenario
  • Abbott Diagnostics
  • Beckman Coulter
  • Becton, Dickinson
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

PART 15: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: IVD market in Europe 2015-2020 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Segmentation of IVD market in Europe by application 2015
  • Exhibit 05: POCT devices market in Europe 2015-2020 ($ billions)
  • Exhibit 06: Immunodiagnostics market in Europe 2015-2020 ($ billions)
  • Exhibit 07: Blood glucose monitoring devices market in Europe 2015-2020 ($ billions)
  • Exhibit 08: Molecular diagnostic market in Europe 2015-2020 ($ billions)
  • Exhibit 09: Hematology devices market in Europe 2015-2020 ($ billions)
  • Exhibit 10: Microbiology devices market in Europe 2015-2020 ($ millions)
  • Exhibit 11: Tissue diagnostics market in Europe 2015-2020 ($ millions)
  • Exhibit 12: Coagulation testing devices market in Europe 2015-2020 ($ millions)
  • Exhibit 13: Segmentation of IVD market in Europe by geography 2015
  • Exhibit 14: IVD market in Germany 2015-2020 ($ billions)
  • Exhibit 15: IVD market in France 2015-2020 ($ billions)
  • Exhibit 16: IVD market in UK 2015-2020 ($ billions)
  • Exhibit 17: IVD market in Italy 2015-2020 ($ billions)
  • Exhibit 18: IVD market in Spain 2015-2020 ($ billions)
  • Exhibit 19: IVD market in Benelux 2015-2020 ($ millions)
  • Exhibit 20: IVD market in Nordic countries 2015-2020 ($ billions)
  • Exhibit 21: Impact of drivers
  • Exhibit 22: Impact of drivers and challenges
  • Exhibit 23: Abbott Diagnostics: Key takeaways
  • Exhibit 24: Product offerings
  • Exhibit 25: Beckman Coulter: Key takeaways
  • Exhibit 26: Product offerings
  • Exhibit 27: Becton, Dickinson: Key takeaways
  • Exhibit 28: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 29: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 (billions)
  • Exhibit 30: Roche Diagnostics: Geographical segmentation by revenue 2014
  • Exhibit 31: Roche Diagnostics: Geographical segmentation by revenue 2013 and 2014 (billions)
  • Exhibit 32: Roche Diagnostics: Segmentation by revenue in EMEA 2014
  • Exhibit 33: Roche Diagnostics: Key takeaways
  • Exhibit 34: Siemens Healthcare: Key takeaways
  • Exhibit 35: Thermo Fisher Scientific: Geographical segmentation by revenue 2014
  • Exhibit 36: Thermo Fisher Scientific: Key takeaways
Back to Top